Title: Pharmacokinetics of lansoprazole and its main metabolites after single intravenous doses in healthy Chinese subjects.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20121101
Title: Effects of CYP2C19 polymorphism on the pharmacokinetics of lansoprazole and its main metabolites in healthy Chinese subjects.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20110601
Title: The effect of CYP2C19 activity on pharmacokinetics of lansoprazole and its active metabolites in healthy subjects.
Journal: Pharmaceutical biology 20100801
Title: Potential of lansoprazole as a novel probe for cytochrome P450 3A activity by measuring lansoprazole sulfone in human liver microsomes.
Journal: Biological & pharmaceutical bulletin 20090801
Title: Simultaneous determination of lansoprazole and its metabolites 5'-hydroxy lansoprazole and lansoprazole sulphone in human plasma by LC-MS/MS: application to a pharmacokinetic study in healthy volunteers.
Journal: Journal of pharmaceutical and biomedical analysis 20081201
Title: Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.
Journal: Xenobiotica; the fate of foreign compounds in biological systems 20060101
Title: Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.
Journal: British journal of clinical pharmacology 20050701
Title: Effects of clarithromycin on lansoprazole pharmacokinetics between CYP2C19 genotypes.
Journal: British journal of clinical pharmacology 20050301
Title: Determination of lansoprazole and two of its metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050225
Title: Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes.
Journal: European journal of clinical pharmacology 20041101
Title: Effects of fluvoxamine on lansoprazole pharmacokinetics in relation to CYP2C19 genotypes.
Journal: Journal of clinical pharmacology 20041101
Title: Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20040525
Title: A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical.
Journal: The Journal of biological chemistry 20030328
Title: Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Journal: Clinical pharmacology and therapeutics 20020701
Title: Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes.
Journal: European journal of clinical pharmacology 20011201
Title: High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes.
Journal: Journal of chromatography. B, Biomedical sciences and applications 20010605
Title: Pharmacokinetic differences between lansoprazole enantiomers and contribution of cytochrome P450 isoforms to enantioselective metabolism of lansoprazole in dogs.
Journal: Biological & pharmaceutical bulletin 20010301
Title: Identification of the human P450 enzymes involved in lansoprazole metabolism.
Journal: The Journal of pharmacology and experimental therapeutics 19960501
